Skip to main content
Log in

Effect of urinary pH on the plasma and urinary kinetics of remoxipride in man

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The influence of urinary pH on the plasma and urinary kinetics of remoxipride in man has been studied in an open crossover trial in ten healthy male volunteers. Ammonium chloride (urinary pH 5.2) and sodium hydrogen carbonate (urinary pH 7.8) were used as pretreatments on two occasions in randomized order. On each occasion remoxipride 50 mg solution was administered orally and plasma and urinary concentrations of the drug were determined by HPLC and plasma prolactin concentrations by RIA.

Remoxipride was rapidly distributed in the body according to a one-compartment model. The mean plasma elimination half-life (t1/2) was 3.6 h in the ammonium chloride experiment and 6.2 h in the sodium hydrogen carbonate experiment. The mean plasma clearance of remoxipride was 141 and 89.9 ml·min−1 in the acidic and alkaline conditions, respectively, and the corresponding mean renal clearances were 58.5 ml·min−1 and 11.7 ml·min−1. The urinary excretion of remoxipride up to 72 h after drug administration was 43.1% and 12.3% following acidification and alkalinization, respectively. Remoxipride induced a similar rapid, transient elevation of plasma prolactin under both conditions.

Thus, the urinary pH has a marked effect on the elimination kinetics of remoxipride. After an overdose, treatment with ammonium chloride might be valuable in hastening elimination of remoxipride from the body.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Beckett AH, Rowland M (1965) Urinary excretion kinetics of amphetamine in man. J Pharm Pharmacol 17: 628–639

    Google Scholar 

  • Gibaldi M, Perrier D (1982) Pharmacokinetics, 2nd edn. Marcel Decker, New York Basel

    Google Scholar 

  • Grind M, Nilsson M-I, Nilsson L, Oxenstierna G, Wahlén A, Sedvall G (1989) Tolerability and pharmacokinetics of remoxipride after single oral and intravenous administration in healthy male volunteers. Psychopharmacology (in press)

  • Hall H, Sällemark M, Jerning E (1986) Effects of remoxipride and some related new substituted salicylamides on rat brain receptors. Acta Pharmacol toxicol 58: 61–70

    Google Scholar 

  • Hollander M, Wolfe DA (1973) Nonparametric statistical methods. John Wiley & Sons New York

    Google Scholar 

  • Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6: 65–70

    Google Scholar 

  • Milne MD, Scribner BH, Crawford MA (1958) Nonionic diffusion and the excretion of weak acids and bases. Am J Med 24: 709–729

    Google Scholar 

  • Nilsson MI, Widerlöv E, Meresaar U, Änggård E (1982) Effect of urinary pH on the disposition of methadone in man. Eur J Clin Pharmacol 22: 337–342

    Google Scholar 

  • Ögren SO, Hall H, Köhler C, Magnusson O, Lindbom LO, Ängeby K, Florvall L (1984) Remoxipride, a new potential antipsychotic compound with selective antidopaminergic action in the rat brain. Eur J Pharmacol 102: 459–474

    Google Scholar 

  • Rowland M, Tozer TN (1980) Clinical pharmacokinetics: Concepts and applications. Lea & Febiger, Philadelphia, p 58

    Google Scholar 

  • Sedman AJ, Wagner JG (1976) CSTRIP — a Fortran IV computer program for obtaining initial polyexponential parameter extimates. J Pharm Sci 65: 2006–1010

    Google Scholar 

  • Weiner JM, Mudge GH (1964) Renal tubular mechanisms for excretion of organic acids and bases. Am J Med 36: 743–762

    Google Scholar 

  • Widerlöv E (1984) Remoxipride — a potential antipsychotic drug with selective dopamine D2-receptor properties. Clin Neuropharmacol 7 [Suppl II]: 554–555

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Widerlöv, E., Termander, B. & Nilsson, MI. Effect of urinary pH on the plasma and urinary kinetics of remoxipride in man. Eur J Clin Pharmacol 37, 359–363 (1989). https://doi.org/10.1007/BF00558500

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00558500

Key words

Navigation